Product NDC: | 60977-144 |
Proprietary Name: | Dopram |
Non Proprietary Name: | DOXAPRAM HYDROCHLORIDE |
Active Ingredient(s): | 20 mg/mL & nbsp; DOXAPRAM HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60977-144 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA014879 |
Marketing Category: | NDA |
Start Marketing Date: | 20101129 |
Package NDC: | 60977-144-02 |
Package Description: | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) |
NDC Code | 60977-144-02 |
Proprietary Name | Dopram |
Package Description | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) |
Product NDC | 60977-144 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DOXAPRAM HYDROCHLORIDE |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101129 |
Marketing Category Name | NDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DOXAPRAM HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC] |